Interestingly, in contrast to tumor cDC1s, we corroborate that tumor monocytes and macrophages activate IRE1 RNase at the B16 tumor site, indicating that tumor-infiltrating myeloid cells set different thresholds for triggering IRE1/XBP1s activity. Here, ERN1 is linked to neoplasm.